Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Neomed Management
Oslo, Norway
A
1-10 Employees
1997
Key takeaway
NeoMed Management is an investment firm focused on the healthcare industry, specifically targeting emerging companies that are developing innovative medical products. Their portfolio includes investments across pharmaceuticals, medical devices, and diagnostics, which align with the advancements in nanomedicine.
Reference
Core business
Neomed - Homepage
Nacamed
Oslo, Norway
A
1-10 Employees
2017
Key takeaway
Nacamed is focused on advancing human health through targeted drug delivery, leveraging its expertise in Silicon particle production. This aligns with the principles of nanomedicine, aiming to develop innovative treatment methods.
Reference
Core business
Nacamed - About Us
Nacamed is a Norwegian spin-off company of Dynatec AS. Dynatec has through the 10 last years investigated in the production of Silicon particles, and has acquired unique competencies in this area. Nacamed aims is to combine these physical competencies with the clinical competencies in the pharmaceutical industry to create a new generation of treatment methods. Our vision is to contribute to human health through targeted drug delivery.
CrayoNano
Trondheim, Norway
A
11-50 Employees
2012
Key takeaway
CrayoNano is focused on developing nanomaterial-based semiconductors that address global health and environmental challenges. Their first product, a UV-C LED, targets the growing market for disinfection, highlighting their commitment to innovative solutions for a healthier future.
Reference
Core business
CrayoNano | About
Our vision at CrayoNano is to enable solutions for a more sustainable and healthier life for everyone.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Nordic Nanovector
Oslo, Norway
A
11-50 Employees
2009
Key takeaway
Thor Medical has developed a reliable and environmentally friendly production technology for alpha emitters, which are essential in promising radionuclide therapy for cancer treatment. This innovation addresses the current supply challenges and supports the advancement of nanomedicine.
Reference
Core business
Our company | Nordicnanovector
Nordic Nanovector is committed to develop, manufacture and deliver innovative therapies to patients in an effort to address major unmet medical needs and advance cancer care.
NT Invest AS
Oslo, Norway
A
1-10 Employees
2008
Key takeaway
Nano Tech Elements, Inc. is a distributor that emphasizes delivering high-quality, tailored electronic components and services, which may be relevant to advancements in nanomedicine technology.
Reference
Product
891-175185-401 - Nano Tech Elements Inc.
M2 GLOBAL
Glycanova AS
Fredrikstad, Norway
A
1-10 Employees
2009
Key takeaway
GlycaNova is a Norwegian biotechnology company that is developing proprietary beta-glucans derived from medicinal mushrooms, which are being explored as adjunct therapies in cancer treatment. They are currently conducting a pioneering clinical trial for late-stage colorectal cancer patients, highlighting their focus on innovative approaches to modulate the immune system.
Reference
Core business
GlycaNova
GlycaNova develops, manufactures and markets nutraceuticals and active pharmaceutical ingredients from Basidiomycetes using patented fermentation and separation technology.
NEC OncoImmunity AS
Oslo, Norway
A
11-50 Employees
2014
Key takeaway
NEC OncoImmunity AS is a biotech company that utilizes artificial intelligence to enhance personalized cancer immunotherapy through the prediction of immunogenic antigens. Their innovative machine-learning software addresses critical knowledge gaps in developing targeted treatments for cancer and infectious diseases.
Reference
Core business
NEC OncoImmunity AS
OncoloMed AS
Stavanger, Norway
A
1-10 Employees
2011
Key takeaway
OncoloMed is dedicated to providing innovative cancer treatments and empowering patients in their treatment journey. With a focus on patient care and access to leading oncologists, they aim to facilitate choices that can enhance the fight against cancer.
Reference
Core business
About | Oncolomed
Med Storm Innovation AS
Oslo, Norway
A
1-10 Employees
1998
Key takeaway
Med-Storm Innovation is a medical technology company that has developed a wearable sensor for real-time pain assessment, utilizing skin conductance analysis. Their innovative approach may have implications for nanomedicine by enhancing pain management techniques through advanced monitoring technology.
Reference
Product
Technology | MedStorm
nanoCaps
Horten, Norway
A
1-10 Employees
2021
Key takeaway
The company specializes in nanotechnology, particularly in the development of supercapacitors that offer significantly higher energy density compared to traditional technologies. Their innovative products are backed by over 15 years of research and a strong patent portfolio.
Reference
Core business
About - nanoCaps
Technologies which have been searched by others and may be interesting for you:
When exploring the nanomedicine industry in Norway, several key considerations come into play. The regulatory framework is crucial, as the Norwegian Medicines Agency oversees compliance with stringent EU regulations, ensuring that nanomedicine products meet safety and efficacy standards. Understanding these regulations is vital for companies seeking to innovate within this space. Additionally, the competitive landscape is shaped by a mix of established firms and startups, many of which are engaged in cutting-edge research and collaborations with universities and research institutes. Challenges such as funding and market entry can pose hurdles, but Norway also offers significant opportunities, especially with its strong emphasis on biotechnology research and development. Environmental concerns related to nanomaterials should not be overlooked, as there is increasing scrutiny on their ecological impact and safety. The global market relevance of nanomedicine continues to grow, driven by advancements in personalized medicine and targeted therapies, which presents further opportunities for Norwegian companies to position themselves strategically on the international stage. Overall, a thorough understanding of these factors will aid in navigating the complexities of the nanomedicine sector in Norway, ultimately paving the way for informed decision-making and successful engagement in this innovative field.
Some interesting numbers and facts about your company results for Nanomedicine
| Country with most fitting companies | Norway |
| Amount of fitting manufacturers | 71 |
| Amount of suitable service providers | 29 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1997 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Nanomedicine
What are related technologies to Nanomedicine?
Based on our calculations related technologies to Nanomedicine are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Who are Start-Ups in the field of Nanomedicine?
Start-Ups who are working in Nanomedicine are nanoCaps
Which industries are mostly working on Nanomedicine?
The most represented industries which are working in Nanomedicine are Medical, Other, Biotechnology, Healthcare, IT, Software and Services
How does ensun find these Nanomedicine Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.